Fora Capital, LLC Fate Therapeutics Inc Transaction History

Fora Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$67.25 - $92.52 $258,509 - $355,646	-3,844 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$72.16 - $117.4 $513,418 - $835,301	-7,115 Reduced 64.92%	3,844 $317 Million
Q4 2020 Feb 12, 2021	BUY	$38.09 - $100.95 $373,167 - $989,007	9,797 Added 843.12%	10,959 $996,000
Q3 2020 Nov 13, 2020	SELL	$30.41 - $40.5 $58,265 - $77,598	-1,916 Reduced 62.25%	1,162 $46 Million
Q2 2020 Aug 14, 2020	BUY	$20.21 - $35.23 $12,348 - $21,525	611 Added 24.77%	3,078 $106 Million
Q1 2020 May 15, 2020	BUY	$17.28 - $31.88 $42,629 - $78,647	2,467 New	2,467 $54,000

176

113M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $123M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.